Formation of HIV elongation complex in the absence of HIV Tat

Pathway network for the Formation of HIV elongation complex in the absence of HIV Tat SuperPath

Sources:

Reactome
WikiPathways

Pathways in the Formation of HIV elongation complex in the absence of HIV Tat SuperPath

#	Name	Source	Genes
1	Formation of HIV elongation complex in the absence of HIV Tat	Reactome	CCNH CCNK CCNT1 CCNT2 CDK7 CDK9 CTDP1 ELL ELOA ELOA2 ELOB ELOC ERCC2 ERCC3 GTF2F1 GTF2F2 GTF2H1 GTF2H2 GTF2H3 GTF2H4 GTF2H5 MNAT1 NCBP1 NCBP2 NELFA NELFB NELFCD NELFE POLR2A POLR2B POLR2C POLR2D POLR2E POLR2F POLR2G POLR2H POLR2I POLR2J POLR2K POLR2L SSRP1 SUPT16H SUPT4H1 SUPT5H TCEA1 (see all 45) (see less)
2	RNA Polymerase II Pre-transcription Events	Reactome	AFF4 CCNH CCNK CCNT1 CCNT2 CDC73 CDK7 CDK9 CTDP1 CTR9 EAF1 EAF2 ELL ELOA ELOA2 ELOB ELOC ERCC2 ERCC3 GTF2A1 GTF2A2 GTF2B GTF2E1 GTF2E2 GTF2F1 GTF2F2 GTF2H1 GTF2H2 GTF2H3 GTF2H4 GTF2H5 IWS1 LEO1 MLLT1 MLLT3 MNAT1 NCBP1 NCBP2 NELFA NELFB NELFCD NELFE PAF1 POLR2A POLR2B POLR2C POLR2D POLR2E POLR2F POLR2G POLR2H POLR2I POLR2J POLR2K POLR2L RTF1 SKIC8 SSRP1 SUPT16H SUPT4H1 SUPT5H SUPT6H TAF1 TAF10 TAF11 TAF12 TAF13 TAF15 TAF1L TAF2 TAF3 TAF4 TAF4B TAF5 TAF6 TAF7 TAF7L TAF9 TAF9B TBP TCEA1 (see all 81) (see less)
3	RNA polymerase II transcribes snRNA genes	Reactome	CCNK CCNT1 CCNT2 CDK7 CDK9 ELL ELL2 ELL3 GTF2A1 GTF2A2 GTF2B GTF2E1 GTF2E2 GTF2F1 GTF2F2 ICE1 ICE2 INTS1 INTS10 INTS11 INTS12 INTS13 INTS14 INTS2 INTS3 INTS4 INTS5 INTS6 INTS7 INTS8 INTS9 NABP1 NABP2 NCBP1 NCBP2 PCF11 PHAX POLR2A POLR2B POLR2C POLR2D POLR2E POLR2F POLR2G POLR2H POLR2I POLR2J POLR2K POLR2L POU2F1 POU2F2 RPAP2 RPRD1A RPRD1B RPRD2 SNAPC1 SNAPC2 SNAPC3 SNAPC4 SNAPC5 SP1 SRRT SSU72 SUPT4H1 SUPT5H TAF11 TAF13 TAF5 TAF6 TAF8 TAF9 TBP ZC3H8 ZNF143 (see all 74) (see less)
4	Transcription of the HIV genome	Reactome	CCNH CCNK CCNT1 CCNT2 CDK7 CDK9 CTDP1 ELL ELOA ELOA2 ELOB ELOC ERCC2 ERCC3 GTF2A1 GTF2A2 GTF2B GTF2E1 GTF2E2 GTF2F1 GTF2F2 GTF2H1 GTF2H2 GTF2H3 GTF2H4 GTF2H5 MNAT1 NCBP1 NCBP2 NELFA NELFB NELFCD NELFE POLR2A POLR2B POLR2C POLR2D POLR2E POLR2F POLR2G POLR2H POLR2I POLR2J POLR2K POLR2L RNGTT RNMT SSRP1 SUPT16H SUPT4H1 SUPT5H TAF1 TAF10 TAF11 TAF12 TAF13 TAF15 TAF1L TAF2 TAF3 TAF4 TAF4B TAF5 TAF6 TAF7 TAF7L TAF9 TAF9B TBP TCEA1 (see all 70) (see less)
5	TP53 Regulates Transcription of DNA Repair Genes	Reactome	ATF2 ATM ATR BRCA1 CCNH CCNK CCNT1 CCNT2 CDK12 CDK13 CDK7 CDK9 CHEK1 CTDP1 DDB2 ELL ELOA ELOA2 ELOB ELOC ERCC2 ERCC3 FANCC FANCD2 FANCI FOS GTF2F1 GTF2F2 GTF2H1 GTF2H2 GTF2H3 GTF2H4 GTF2H5 JUN MDC1 MLH1 MNAT1 MSH2 NELFA NELFB NELFCD NELFE PMS2 POLR2A POLR2B POLR2C POLR2D POLR2E POLR2F POLR2G POLR2H POLR2I POLR2J POLR2K POLR2L RAD51D SSRP1 SUPT16H SUPT4H1 SUPT5H TCEA1 TP53 (see all 62) (see less)
6	Formation of RNA Pol II elongation complex	Reactome	AFF4 CCNH CCNK CCNT1 CCNT2 CDC73 CDK7 CDK9 CTDP1 CTR9 EAF1 EAF2 ELL ELOA ELOA2 ELOB ELOC ERCC2 ERCC3 GTF2F1 GTF2F2 GTF2H1 GTF2H2 GTF2H3 GTF2H4 GTF2H5 IWS1 LEO1 MLLT1 MLLT3 MNAT1 NCBP1 NCBP2 NELFA NELFB NELFCD NELFE PAF1 POLR2A POLR2B POLR2C POLR2D POLR2E POLR2F POLR2G POLR2H POLR2I POLR2J POLR2K POLR2L RTF1 SKIC8 SSRP1 SUPT16H SUPT4H1 SUPT5H SUPT6H TCEA1 (see all 58) (see less)
7	RNA Polymerase II Transcription Elongation	Reactome	AFF4 CCNH CCNK CCNT1 CCNT2 CDC73 CDK7 CDK9 CTDP1 CTR9 EAF1 EAF2 ELL ELOA ELOA2 ELOB ELOC ERCC2 ERCC3 GTF2F1 GTF2F2 GTF2H1 GTF2H2 GTF2H3 GTF2H4 GTF2H5 IWS1 LEO1 MLLT1 MLLT3 MNAT1 NCBP1 NCBP2 NELFA NELFB NELFCD NELFE PAF1 POLR2A POLR2B POLR2C POLR2D POLR2E POLR2F POLR2G POLR2H POLR2I POLR2J POLR2K POLR2L RTF1 SKIC8 SSRP1 SUPT16H SUPT4H1 SUPT5H SUPT6H TCEA1 (see all 58) (see less)
8	HIV Transcription Elongation	Reactome	CCNH CCNT1 CDK7 CDK9 CTDP1 ELL ELOA ELOA2 ELOB ELOC ERCC2 ERCC3 GTF2F1 GTF2F2 GTF2H1 GTF2H2 GTF2H3 GTF2H4 GTF2H5 MNAT1 NCBP1 NCBP2 NELFA NELFB NELFCD NELFE POLR2A POLR2B POLR2C POLR2D POLR2E POLR2F POLR2G POLR2H POLR2I POLR2J POLR2K POLR2L SSRP1 SUPT16H SUPT4H1 SUPT5H TCEA1 (see all 43) (see less)
9	Tat-mediated elongation of the HIV-1 transcript	Reactome	CCNH CCNT1 CDK7 CDK9 CTDP1 ELL ELOA ELOA2 ELOB ELOC ERCC2 ERCC3 GTF2F1 GTF2F2 GTF2H1 GTF2H2 GTF2H3 GTF2H4 GTF2H5 MNAT1 NCBP1 NCBP2 NELFA NELFB NELFCD NELFE POLR2A POLR2B POLR2C POLR2D POLR2E POLR2F POLR2G POLR2H POLR2I POLR2J POLR2K POLR2L SSRP1 SUPT16H SUPT4H1 SUPT5H TCEA1 (see all 43) (see less)
10	Formation of HIV-1 elongation complex containing HIV-1 Tat	Reactome	CCNH CCNT1 CDK7 CDK9 CTDP1 ELL ELOA ELOA2 ELOB ELOC ERCC2 ERCC3 GTF2F1 GTF2F2 GTF2H1 GTF2H2 GTF2H3 GTF2H4 GTF2H5 MNAT1 NCBP1 NCBP2 NELFA NELFB NELFCD NELFE POLR2A POLR2B POLR2C POLR2D POLR2E POLR2F POLR2G POLR2H POLR2I POLR2J POLR2K POLR2L SSRP1 SUPT16H SUPT4H1 SUPT5H TCEA1 (see all 43) (see less)
11	Pausing and recovery of HIV elongation	Reactome	CCNK CCNT1 CCNT2 CDK9 CTDP1 ELL ELOA ELOA2 ELOB ELOC GTF2F1 GTF2F2 NELFA NELFB NELFCD NELFE POLR2A POLR2B POLR2C POLR2D POLR2E POLR2F POLR2G POLR2H POLR2I POLR2J POLR2K POLR2L SSRP1 SUPT16H SUPT4H1 SUPT5H TCEA1 (see all 33) (see less)
12	Formation of the HIV-1 Early Elongation Complex	Reactome	CCNH CDK7 CTDP1 ERCC2 ERCC3 GTF2F1 GTF2F2 GTF2H1 GTF2H2 GTF2H3 GTF2H4 GTF2H5 MNAT1 NCBP1 NCBP2 NELFA NELFB NELFCD NELFE POLR2A POLR2B POLR2C POLR2D POLR2E POLR2F POLR2G POLR2H POLR2I POLR2J POLR2K POLR2L SUPT4H1 SUPT5H (see all 33) (see less)
13	HIV elongation arrest and recovery	Reactome	CCNK CCNT1 CCNT2 CDK9 CTDP1 ELL ELOA ELOA2 ELOB ELOC GTF2F1 GTF2F2 NELFA NELFB NELFCD NELFE POLR2A POLR2B POLR2C POLR2D POLR2E POLR2F POLR2G POLR2H POLR2I POLR2J POLR2K POLR2L SSRP1 SUPT16H SUPT4H1 SUPT5H TCEA1 (see all 33) (see less)
14	Formation of the Early Elongation Complex	Reactome	CCNH CDK7 CTDP1 ERCC2 ERCC3 GTF2F1 GTF2F2 GTF2H1 GTF2H2 GTF2H3 GTF2H4 GTF2H5 MNAT1 NCBP1 NCBP2 NELFA NELFB NELFCD NELFE POLR2A POLR2B POLR2C POLR2D POLR2E POLR2F POLR2G POLR2H POLR2I POLR2J POLR2K POLR2L SUPT4H1 SUPT5H (see all 33) (see less)
15	Pausing and recovery of Tat-mediated HIV elongation	Reactome	CCNT1 CDK9 CTDP1 ELL ELOA ELOA2 ELOB ELOC GTF2F1 GTF2F2 NELFA NELFB NELFCD NELFE POLR2A POLR2B POLR2C POLR2D POLR2E POLR2F POLR2G POLR2H POLR2I POLR2J POLR2K POLR2L SSRP1 SUPT16H SUPT4H1 SUPT5H TCEA1 (see all 31) (see less)
16	Tat-mediated HIV elongation arrest and recovery	Reactome	CCNT1 CDK9 CTDP1 ELL ELOA ELOA2 ELOB ELOC GTF2F1 GTF2F2 NELFA NELFB NELFCD NELFE POLR2A POLR2B POLR2C POLR2D POLR2E POLR2F POLR2G POLR2H POLR2I POLR2J POLR2K POLR2L SSRP1 SUPT16H SUPT4H1 SUPT5H TCEA1 (see all 31) (see less)
17	mRNA Capping	Reactome	CCNH CDK7 ERCC2 ERCC3 GTF2F1 GTF2F2 GTF2H1 GTF2H2 GTF2H3 GTF2H4 GTF2H5 MNAT1 NCBP1 NCBP2 POLR2A POLR2B POLR2C POLR2D POLR2E POLR2F POLR2G POLR2H POLR2I POLR2J POLR2K POLR2L RNGTT RNMT SUPT5H (see all 29) (see less)
18	PIWI-interacting RNA (piRNA) biogenesis	Reactome	ASZ1 DDX4 FKBP6 HENMT1 HSP90AA1 MAEL MOV10L1 MYBL1 PIWIL1 PIWIL2 PIWIL4 PLD6 POLR2A POLR2B POLR2C POLR2D POLR2E POLR2F POLR2G POLR2H POLR2I POLR2J POLR2K POLR2L TDRD1 TDRD12 TDRD6 TDRD9 TDRKH (see all 29) (see less)
19	RNA Pol II CTD phosphorylation and interaction with CE	Reactome	CCNH CDK7 ERCC2 ERCC3 GTF2F1 GTF2F2 GTF2H1 GTF2H2 GTF2H3 GTF2H4 GTF2H5 MNAT1 POLR2A POLR2B POLR2C POLR2D POLR2E POLR2F POLR2G POLR2H POLR2I POLR2J POLR2K POLR2L RNGTT RNMT SUPT5H (see all 27) (see less)
20	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	Reactome	CCNH CDK7 ERCC2 ERCC3 GTF2F1 GTF2F2 GTF2H1 GTF2H2 GTF2H3 GTF2H4 GTF2H5 MNAT1 POLR2A POLR2B POLR2C POLR2D POLR2E POLR2F POLR2G POLR2H POLR2I POLR2J POLR2K POLR2L RNGTT RNMT SUPT5H (see all 27) (see less)
21	FGFR2 alternative splicing	Reactome	ESRP1 ESRP2 GTF2F1 GTF2F2 HNRNPA1 HNRNPF HNRNPH1 HNRNPM NCBP1 NCBP2 POLR2A POLR2B POLR2C POLR2D POLR2E POLR2F POLR2G POLR2H POLR2I POLR2J POLR2K POLR2L PTBP1 RBFOX2 TIA1 TIAL1 (see all 26) (see less)
22	MicroRNA (miRNA) biogenesis	Reactome	AGO1 AGO2 AGO3 AGO4 BCDIN3D DGCR8 DICER1 DROSHA POLR2A POLR2B POLR2C POLR2D POLR2E POLR2F POLR2G POLR2H POLR2I POLR2J POLR2K POLR2L PRKRA RAN TARBP2 XPO5 (see all 24) (see less)
23	Abortive elongation of HIV-1 transcript in the absence of Tat	Reactome	CTDP1 GTF2F1 GTF2F2 NCBP1 NCBP2 NELFA NELFB NELFCD NELFE POLR2A POLR2B POLR2C POLR2D POLR2E POLR2F POLR2G POLR2H POLR2I POLR2J POLR2K POLR2L SUPT4H1 SUPT5H (see all 23) (see less)
24	miRNA biogenesis	WikiPathways	DGCR8 DICER1 DROSHA RAN TARBP2 XPO5 (see all 6) (see less)
25	Interactions of Tat with host cellular proteins	Reactome	CCNT1 CDK9

Gene overlap in member pathways for Formation of HIV elongation complex in the absence of HIV Tat SuperPath

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	POLR2A	RNA Polymerase II Subunit A	Protein Coding	23
2	POLR2B	RNA Polymerase II Subunit B	Protein Coding	23
3	POLR2C	RNA Polymerase II Subunit C	Protein Coding	23
4	POLR2D	RNA Polymerase II Subunit D	Protein Coding	23
5	POLR2E	RNA Polymerase II, I And III Subunit E	Protein Coding	23
6	POLR2F	RNA Polymerase II, I And III Subunit F	Protein Coding	23
7	POLR2G	RNA Polymerase II Subunit G	Protein Coding	23
8	POLR2H	RNA Polymerase II, I And III Subunit H	Protein Coding	23
9	POLR2I	RNA Polymerase II Subunit I	Protein Coding	23
10	POLR2J	RNA Polymerase II Subunit J	Protein Coding	23
11	POLR2K	RNA Polymerase II, I And III Subunit K	Protein Coding	23
12	POLR2L	RNA Polymerase II, I And III Subunit L	Protein Coding	23
13	GTF2F1	General Transcription Factor IIF Subunit 1	Protein Coding	21
14	GTF2F2	General Transcription Factor IIF Subunit 2	Protein Coding	21
15	SUPT5H	SPT5 Homolog, DSIF Elongation Factor Subunit	Protein Coding	20
16	SUPT4H1	SPT4 Homolog, DSIF Elongation Factor Subunit	Protein Coding	17
17	NELFB	Negative Elongation Factor Complex Member B	Protein Coding	16
18	NELFCD	Negative Elongation Factor Complex Member C/D	Protein Coding	16
19	NELFA	Negative Elongation Factor Complex Member A	Protein Coding	16
20	NELFE	Negative Elongation Factor Complex Member E	Protein Coding	16
21	CTDP1	CTD Phosphatase Subunit 1	Protein Coding	16
22	CDK7	Cyclin Dependent Kinase 7	Protein Coding	15
23	CDK9	Cyclin Dependent Kinase 9	Protein Coding	15
24	CCNT1	Cyclin T1	Protein Coding	15
25	ERCC2	ERCC Excision Repair 2, TFIIH Core Complex Helicase Subunit	Protein Coding	14
26	ERCC3	ERCC Excision Repair 3, TFIIH Core Complex Helicase Subunit	Protein Coding	14
27	NCBP2	Nuclear Cap Binding Protein Subunit 2	Protein Coding	14
28	GTF2H1	General Transcription Factor IIH Subunit 1	Protein Coding	14
29	GTF2H2	General Transcription Factor IIH Subunit 2	Protein Coding	14
30	GTF2H3	General Transcription Factor IIH Subunit 3	Protein Coding	14
31	GTF2H4	General Transcription Factor IIH Subunit 4	Protein Coding	14
32	GTF2H5	General Transcription Factor IIH Subunit 5	Protein Coding	14
33	MNAT1	MNAT1 Component Of CDK Activating Kinase	Protein Coding	14
34	NCBP1	Nuclear Cap Binding Protein Subunit 1	Protein Coding	14
35	ELL	Elongation Factor For RNA Polymerase II	Protein Coding	14
36	CCNH	Cyclin H	Protein Coding	14
37	SUPT16H	SPT16 Homolog, Facilitates Chromatin Remodeling Subunit	Protein Coding	13
38	ELOA2	Elongin A2	Protein Coding	13
39	SSRP1	Structure Specific Recognition Protein 1	Protein Coding	13
40	TCEA1	Transcription Elongation Factor A1	Protein Coding	13
41	ELOC	Elongin C	Protein Coding	13
42	ELOB	Elongin B	Protein Coding	13
43	ELOA	Elongin A	Protein Coding	13
44	CCNK	Cyclin K	Protein Coding	9
45	CCNT2	Cyclin T2	Protein Coding	9
46	RNMT	RNA Guanine-7 Methyltransferase	Protein Coding	4
47	RNGTT	RNA Guanylyltransferase And 5''-Phosphatase	Protein Coding	4
48	LEO1	LEO1 Component Of Paf1/RNA Polymerase II Complex	Protein Coding	3
49	RTF1	RTF1 Homolog, Paf1/RNA Polymerase II Complex Component	Protein Coding	3
50	AFF4	ALF Transcription Elongation Factor 4	Protein Coding	3
51	GTF2A1	General Transcription Factor IIA Subunit 1	Protein Coding	3
52	GTF2A2	General Transcription Factor IIA Subunit 2	Protein Coding	3
53	GTF2B	General Transcription Factor IIB	Protein Coding	3
54	GTF2E1	General Transcription Factor IIE Subunit 1	Protein Coding	3
55	GTF2E2	General Transcription Factor IIE Subunit 2	Protein Coding	3
56	MLLT1	MLLT1 Super Elongation Complex Subunit	Protein Coding	3
57	MLLT3	MLLT3 Super Elongation Complex Subunit	Protein Coding	3
58	PAF1	PAF1 Component Of Paf1/RNA Polymerase II Complex	Protein Coding	3
59	IWS1	Interacts With SUPT6H, CTD Assembly Factor 1	Protein Coding	3
60	EAF2	ELL Associated Factor 2	Protein Coding	3
61	SUPT6H	SPT6 Homolog, Histone Chaperone And Transcription Elongation Factor	Protein Coding	3
62	TAF5	TATA-Box Binding Protein Associated Factor 5	Protein Coding	3
63	TAF6	TATA-Box Binding Protein Associated Factor 6	Protein Coding	3
64	TAF9	TATA-Box Binding Protein Associated Factor 9	Protein Coding	3
65	TAF11	TATA-Box Binding Protein Associated Factor 11	Protein Coding	3
66	TAF13	TATA-Box Binding Protein Associated Factor 13	Protein Coding	3
67	TBP	TATA-Box Binding Protein	Protein Coding	3
68	CDC73	Cell Division Cycle 73	Protein Coding	3
69	SKIC8	SKI8 Subunit Of Superkiller Complex	Protein Coding	3
70	EAF1	ELL Associated Factor 1	Protein Coding	3
71	CTR9	CTR9 Component Of Paf1/RNA Polymerase II Complex	Protein Coding	3
72	TAF1L	TATA-Box Binding Protein Associated Factor 1 Like	Protein Coding	2
73	TAF9B	TATA-Box Binding Protein Associated Factor 9b	Protein Coding	2
74	TAF7L	TATA-Box Binding Protein Associated Factor 7 Like	Protein Coding	2
75	TAF1	TATA-Box Binding Protein Associated Factor 1	Protein Coding	2
76	TAF2	TATA-Box Binding Protein Associated Factor 2	Protein Coding	2
77	TAF4	TATA-Box Binding Protein Associated Factor 4	Protein Coding	2
78	TAF4B	TATA-Box Binding Protein Associated Factor 4b	Protein Coding	2
79	TAF7	TATA-Box Binding Protein Associated Factor 7	Protein Coding	2
80	TAF10	TATA-Box Binding Protein Associated Factor 10	Protein Coding	2
81	TAF12	TATA-Box Binding Protein Associated Factor 12	Protein Coding	2
82	TAF15	TATA-Box Binding Protein Associated Factor 15	Protein Coding	2
83	TAF3	TATA-Box Binding Protein Associated Factor 3	Protein Coding	2
84	DICER1	Dicer 1, Ribonuclease III	Protein Coding	2
85	DROSHA	Drosha Ribonuclease III	Protein Coding	2
86	DGCR8	DGCR8 Microprocessor Complex Subunit	Protein Coding	2
87	XPO5	Exportin 5	Protein Coding	2
88	RAN	RAN, Member RAS Oncogene Family	Protein Coding	2
89	TARBP2	TARBP2 Subunit Of RISC Loading Complex	Protein Coding	2
90	SNAPC5	Small Nuclear RNA Activating Complex Polypeptide 5	Protein Coding	1
91	TAF8	TATA-Box Binding Protein Associated Factor 8	Protein Coding	1
92	ELL2	Elongation Factor For RNA Polymerase II 2	Protein Coding	1
93	RPRD2	Regulation Of Nuclear Pre-MRNA Domain Containing 2	Protein Coding	1
94	ICE1	Interactor Of Little Elongation Complex ELL Subunit 1	Protein Coding	1
95	INTS7	Integrator Complex Subunit 7	Protein Coding	1
96	INTS1	Integrator Complex Subunit 1	Protein Coding	1
97	INTS6	Integrator Complex Subunit 6	Protein Coding	1
98	SSU72	SSU72 Homolog, RNA Polymerase II CTD Phosphatase	Protein Coding	1
99	PCF11	PCF11 Cleavage And Polyadenylation Factor Subunit	Protein Coding	1
100	SRRT	Serrate, RNA Effector Molecule	Protein Coding	1
101	PHAX	Phosphorylated Adaptor For RNA Export	Protein Coding	1
102	POU2F1	POU Class 2 Homeobox 1	Protein Coding	1
103	POU2F2	POU Class 2 Homeobox 2	Protein Coding	1
104	INTS11	Integrator Complex Subunit 11	Protein Coding	1
105	INTS10	Integrator Complex Subunit 10	Protein Coding	1
106	RPRD1A	Regulation Of Nuclear Pre-MRNA Domain Containing 1A	Protein Coding	1
107	INTS8	Integrator Complex Subunit 8	Protein Coding	1
108	INTS13	Integrator Complex Subunit 13	Protein Coding	1
109	INTS9	Integrator Complex Subunit 9	Protein Coding	1
110	INTS12	Integrator Complex Subunit 12	Protein Coding	1
111	INTS2	Integrator Complex Subunit 2	Protein Coding	1
112	RPRD1B	Regulation Of Nuclear Pre-MRNA Domain Containing 1B	Protein Coding	1
113	NABP1	Nucleic Acid Binding Protein 1	Protein Coding	1
114	INTS3	Integrator Complex Subunit 3	Protein Coding	1
115	SNAPC1	Small Nuclear RNA Activating Complex Polypeptide 1	Protein Coding	1
116	SNAPC2	Small Nuclear RNA Activating Complex Polypeptide 2	Protein Coding	1
117	SNAPC3	Small Nuclear RNA Activating Complex Polypeptide 3	Protein Coding	1
118	SNAPC4	Small Nuclear RNA Activating Complex Polypeptide 4	Protein Coding	1
119	SP1	Sp1 Transcription Factor	Protein Coding	1
120	ZNF143	Zinc Finger Protein 143	Protein Coding	1
121	NABP2	Nucleic Acid Binding Protein 2	Protein Coding	1
122	ICE2	Interactor Of Little Elongation Complex ELL Subunit 2	Protein Coding	1
123	RPAP2	RNA Polymerase II Associated Protein 2	Protein Coding	1
124	ELL3	Elongation Factor For RNA Polymerase II 3	Protein Coding	1
125	INTS5	Integrator Complex Subunit 5	Protein Coding	1
126	INTS14	Integrator Complex Subunit 14	Protein Coding	1
127	ZC3H8	Zinc Finger CCCH-Type Containing 8	Protein Coding	1
128	INTS4	Integrator Complex Subunit 4	Protein Coding	1
129	CHEK1	Checkpoint Kinase 1	Protein Coding	1
130	ATF2	Activating Transcription Factor 2	Protein Coding	1
131	DDB2	Damage Specific DNA Binding Protein 2	Protein Coding	1
132	FANCC	FA Complementation Group C	Protein Coding	1
133	FANCD2	FA Complementation Group D2	Protein Coding	1
134	FOS	Fos Proto-Oncogene, AP-1 Transcription Factor Subunit	Protein Coding	1
135	JUN	Jun Proto-Oncogene, AP-1 Transcription Factor Subunit	Protein Coding	1
136	MLH1	MutL Homolog 1	Protein Coding	1
137	MSH2	MutS Homolog 2	Protein Coding	1
138	ATM	ATM Serine/Threonine Kinase	Protein Coding	1
139	CDK12	Cyclin Dependent Kinase 12	Protein Coding	1
140	PMS2	PMS1 Homolog 2, Mismatch Repair System Component	Protein Coding	1
141	ATR	ATR Checkpoint Kinase	Protein Coding	1
142	FANCI	FA Complementation Group I	Protein Coding	1
143	RAD51D	RAD51 Paralog D	Protein Coding	1
144	BRCA1	BRCA1 DNA Repair Associated	Protein Coding	1
145	TP53	Tumor Protein P53	Protein Coding	1
146	CDK13	Cyclin Dependent Kinase 13	Protein Coding	1
147	MDC1	Mediator Of DNA Damage Checkpoint 1	Protein Coding	1
148	TDRKH	Tudor And KH Domain Containing	Protein Coding	1
149	HENMT1	HEN Methyltransferase 1	Protein Coding	1
150	TDRD9	Tudor Domain Containing 9	Protein Coding	1
151	ASZ1	Ankyrin Repeat, SAM And Basic Leucine Zipper Domain Containing 1	Protein Coding	1
152	PIWIL4	Piwi Like RNA-Mediated Gene Silencing 4	Protein Coding	1
153	PLD6	Phospholipase D Family Member 6	Protein Coding	1
154	TDRD6	Tudor Domain Containing 6	Protein Coding	1
155	HSP90AA1	Heat Shock Protein 90 Alpha Family Class A Member 1	Protein Coding	1
156	MYBL1	MYB Proto-Oncogene Like 1	Protein Coding	1
157	MOV10L1	Mov10 Like RNA Helicase 1	Protein Coding	1
158	DDX4	DEAD-Box Helicase 4	Protein Coding	1
159	PIWIL2	Piwi Like RNA-Mediated Gene Silencing 2	Protein Coding	1
160	TDRD1	Tudor Domain Containing 1	Protein Coding	1
161	FKBP6	FKBP Prolyl Isomerase Family Member 6 (Inactive)	Protein Coding	1
162	MAEL	Maelstrom Spermatogenic Transposon Silencer	Protein Coding	1
163	TDRD12	Tudor Domain Containing 12	Protein Coding	1
164	PIWIL1	Piwi Like RNA-Mediated Gene Silencing 1	Protein Coding	1
165	RBFOX2	RNA Binding Fox-1 Homolog 2	Protein Coding	1
166	HNRNPA1	Heterogeneous Nuclear Ribonucleoprotein A1	Protein Coding	1
167	HNRNPF	Heterogeneous Nuclear Ribonucleoprotein F	Protein Coding	1
168	HNRNPH1	Heterogeneous Nuclear Ribonucleoprotein H1	Protein Coding	1
169	HNRNPM	Heterogeneous Nuclear Ribonucleoprotein M	Protein Coding	1
170	ESRP1	Epithelial Splicing Regulatory Protein 1	Protein Coding	1
171	PTBP1	Polypyrimidine Tract Binding Protein 1	Protein Coding	1
172	TIA1	TIA1 Cytotoxic Granule Associated RNA Binding Protein	Protein Coding	1
173	TIAL1	TIA1 Cytotoxic Granule Associated RNA Binding Protein Like 1	Protein Coding	1
174	ESRP2	Epithelial Splicing Regulatory Protein 2	Protein Coding	1
175	BCDIN3D	BCDIN3 Domain Containing RNA Methyltransferase	Protein Coding	1
176	AGO3	Argonaute RISC Catalytic Component 3	Protein Coding	1
177	AGO4	Argonaute RISC Component 4	Protein Coding	1
178	AGO1	Argonaute RISC Component 1	Protein Coding	1
179	AGO2	Argonaute RISC Catalytic Component 2	Protein Coding	1
180	PRKRA	Protein Activator Of Interferon Induced Protein Kinase EIF2AK2	Protein Coding	1

Disorders associated with Formation of HIV elongation complex in the absence of HIV Tat SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Human immunodeficiency virus infectious disease	Direct
2	Male infertility	Enrichment	FKBP6, MAEL, MOV10L1, PIWIL1, PLD6, TDRD1, TDRD12, TDRD9	16.00
3	Gastric cancer	Enrichment	ATM, BRCA1, FANCI, MLH1, MSH2, PMS2, RAD51D, TP53	10.56
4	Ovarian cancer	Enrichment	ATM, BRCA1, ERCC2, ERCC3, FANCC, FANCD2, MSH2, PMS2, RAD51D, TP53	10.52
5	Breast cancer	Enrichment	ATM, BRCA1, FANCC, JUN, MLH1, MSH2, PMS2, RAD51D, TP53	10.20
6	Colorectal cancer	Enrichment	ATM, BRCA1, FANCC, FANCI, MLH1, MSH2, PMS2, RAD51D, TP53	9.68
7	Lynch syndrome 1	Enrichment	ATM, MLH1, MSH2, PMS2, RAD51D	9.39
8	Hereditary breast ovarian cancer syndrome	Enrichment	ATM, BRCA1, MLH1, MSH2, PMS2, RAD51D, TP53	8.30
9	Inherited cancer-predisposing syndrome	Enrichment	ATM, BRCA1, ERCC3, FANCC, MLH1, MSH2, PMS2, RAD51D, TP53	8.11
10	Endometrial cancer	Enrichment	ATM, BRCA1, MLH1, MSH2, PMS2	7.49
11	Hereditary breast carcinoma	Enrichment	ATM, BRCA1, MLH1, MSH2, RAD51D, TP53	7.36
12	Azoospermia	Enrichment	HENMT1, MOV10L1, TDRD9, TDRKH	7.10
13	Trichothiodystrophy	Enrichment	ERCC2, ERCC3, GTF2E2, GTF2H5	6.84
14	Pineoblastoma	Enrichment	DICER1, DROSHA	6.79
15	Breast-ovarian cancer, familial 1	Enrichment	ATM, BRCA1, MSH2, RAD51D	6.56
16	Mismatch repair cancer syndrome 1	Enrichment	MLH1, MSH2, PMS2	6.44
17	Rhabdomyosarcoma	Enrichment	BRCA1, MSH2, PMS2, TP53	6.16
18	Bladder cancer	Enrichment	ATM, BRCA1, ERCC2, TP53	5.06
19	Prostate cancer	Enrichment	ATM, BRCA1, RAD51D, TP53	5.06
20	Familial colorectal cancer	Enrichment	MLH1, MSH2, TP53	4.97
21	Xeroderma pigmentosum, variant type	Enrichment	DDB2, ERCC2, ERCC3	4.84
22	Uterine corpus cancer	Enrichment	ATM, BRCA1, MSH2	4.84
23	Fanconi anemia, complementation group a	Enrichment	BRCA1, FANCC, FANCD2, FANCI	4.73
24	Muir-torre syndrome	Enrichment	MLH1, MSH2	4.69
25	Xeroderma pigmentosum-cockayne syndrome complex	Enrichment	ERCC2, ERCC3	4.42
26	Lynch syndrome	Enrichment	MLH1, MSH2, PMS2	4.40
27	Gliosarcoma	Enrichment	ATM, MSH2, TP53	4.31
28	Giant cell glioblastoma	Enrichment	ATM, MSH2, TP53	4.23
29	Adenocarcinoma	Enrichment	ATM, TP53	4.21
30	Hepatoblastoma	Enrichment	ERCC2, MSH2, TP53	3.94
31	Lynch syndrome 4	Enrichment	MSH2, PMS2	3.91
32	Pancreatic cancer	Enrichment	ATM, BRCA1, TP53	3.71
33	Breast-ovarian cancer, familial 2	Enrichment	BRCA1, PMS2	3.69
34	Lymphoma	Enrichment	PMS2, TP53	3.69
35	Glioblastoma	Enrichment	ATM, MSH2	3.69
36	Male infertility with azoospermia or oligozoospermia due to single gene mutation	Enrichment	ASZ1, MOV10L1, TDRD9	3.65
37	Rhabdomyosarcoma, embryonal, 2	Enrichment	DICER1	3.35
38	Dicer1 syndrome	Enrichment	DICER1	3.35
39	Pleuropulmonary blastoma	Enrichment	DICER1	3.35
40	Global developmental delay, lung cysts, overgrowth, and wilms tumor	Enrichment	DICER1	3.35
41	Malignant sertoli-leydig cell tumor of ovary	Enrichment	DICER1	3.35
42	Supratentorial primitive neuroectodermal tumor	Enrichment	DICER1	3.35
43	Gynandroblastoma	Enrichment	DICER1	3.35
44	Dicer1 tumor predisposition	Enrichment	DICER1	3.35
45	Colonic benign neoplasm	Enrichment	ATM, MLH1	3.14
46	Goiter, multinodular 1, with or without sertoli-leydig cell tumors	Enrichment	DICER1	3.05
47	Vertebral anomalies and variable endocrine and t-cell dysfunction	Enrichment	DICER1	3.05
48	Malignant granulosa cell tumor of the ovary	Enrichment	DICER1	3.05
49	Leukemia, chronic lymphocytic	Enrichment	ATM, TP53	3.04
50	Embryonal rhabdomyosarcoma	Enrichment	DICER1	2.75
51	Lung cancer susceptibility 3	Enrichment	CDK12, TP53	2.74
52	Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3	Enrichment	HNRNPA1	2.72
53	Myopathy, distal, 3	Enrichment	HNRNPA1	2.72
54	Amyotrophic lateral sclerosis 20	Enrichment	HNRNPA1	2.72
55	Finnish upper limb-onset distal myopathy	Enrichment	HNRNPA1	2.72
56	Amyotrophic lateral sclerosis 26 with or without frontotemporal dementia	Enrichment	TIA1	2.72
57	Relapsing-remitting multiple sclerosis	Enrichment	HNRNPA1	2.72
58	Xeroderma pigmentosum, complementation group b	Enrichment	ERCC3	2.70
59	Xeroderma pigmentosum, complementation group d	Enrichment	ERCC2	2.70
60	Trichothiodystrophy 2, photosensitive	Enrichment	ERCC3	2.70
61	Xeroderma pigmentosum group b	Enrichment	ERCC3	2.70
62	Cerebrooculofacioskeletal syndrome 2	Enrichment	ERCC2	2.70
63	Trichothiodystrophy 3, photosensitive	Enrichment	GTF2H5	2.70
64	Xeroderma pigmentosum group d	Enrichment	ERCC2	2.70
65	Spermatogenic failure 73	Enrichment	MOV10L1	2.67
66	Spermatogenic failure 77	Enrichment	FKBP6	2.67
67	Spermatogenic failure 30	Enrichment	TDRD9	2.67
68	Diffuse large b-cell lymphoma	Enrichment	PMS2, TP53	2.48
69	Waardenburg syndrome, type 4c	Enrichment	POLR2F	2.45
70	Premature ovarian failure 3	Enrichment	AGO2	2.45
71	Dystonia 16	Enrichment	PRKRA	2.45
72	Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures	Enrichment	AGO1	2.45
73	Peripheral demyelinating neuropathy, central dysmyelination, waardenburg syndrome, and hirschsprung disease	Enrichment	POLR2F	2.45
74	Welander distal myopathy	Enrichment	TIA1	2.42
75	Deafness, autosomal recessive 109	Enrichment	ESRP1	2.42
76	Neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects	Enrichment	HNRNPH1	2.42
77	Parathyroid carcinoma	Enrichment	CDC73	2.37
78	Hyperparathyroidism 2 with jaw tumors	Enrichment	CDC73	2.37
79	Chops syndrome	Enrichment	AFF4	2.37
80	Cdc73-related disorders	Enrichment	CDC73	2.37
81	Intellectual developmental disorder with hypertelorism and distinctive facies	Enrichment	CCNK	2.37
82	Neurodevelopmental disorder with dysmorphic facies and thin corpus callosum	Enrichment	SUPT16H	2.37
83	Hepatocellular carcinoma	Enrichment	PMS2, TP53	2.35
84	Palmoplantar keratoderma, punctate type ii	Enrichment	BRCA1	2.34
85	Seckel syndrome 1	Enrichment	ATR	2.34
86	Bone marrow failure syndrome 5	Enrichment	TP53	2.34
87	Papilloma of choroid plexus	Enrichment	TP53	2.34
88	Basal cell carcinoma 7	Enrichment	TP53	2.34
89	Lynch syndrome 2	Enrichment	MLH1	2.34
90	Anaplastic thyroid carcinoma	Enrichment	TP53	2.34
91	Infant-type hemispheric glioma	Enrichment	BRCA1	2.34
92	Cutaneous telangiectasia and cancer syndrome, familial	Enrichment	ATR	2.34
93	Endometrial serous adenocarcinoma	Enrichment	ATM	2.34
94	Ductal carcinoma in situ	Enrichment	TP53	2.34
95	Mismatch repair cancer syndrome 2	Enrichment	MSH2	2.34
96	Mismatch repair cancer syndrome 4	Enrichment	PMS2	2.34
97	Rectal benign neoplasm	Enrichment	MSH2	2.34
98	Thyroid gland undifferentiated carcinoma	Enrichment	TP53	2.34
99	Small-cell carcinoma of the ovary of hypercalcemic type	Enrichment	TP53	2.34
100	Pituitary cancer	Enrichment	PMS2	2.34
101	Ascending colon cancer	Enrichment	MSH2	2.34
102	Diffuse pediatric-type high-grade glioma, h3-wildtype and idh-wildtype	Enrichment	TP53	2.34
103	Oocyte/zygote/embryo maturation arrest 21	Enrichment	CHEK1	2.34
104	B-cell non-hodgkin lymphoma	Enrichment	ATM	2.34
105	Choroid plexus cancer	Enrichment	TP53	2.34
106	Ovarian cyst	Enrichment	MSH2	2.34
107	Pleomorphic xanthoastrocytoma	Enrichment	TP53	2.34
108	Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome	Enrichment	ATR	2.34
109	Primary peritoneal carcinoma	Enrichment	BRCA1	2.34
110	Congenital cataracts, facial dysmorphism, and neuropathy	Enrichment	CTDP1	2.31
111	Waardenburg syndrome, type 2a	Enrichment	POLR2F	2.28
112	Lessel-kreienkamp syndrome	Enrichment	AGO2	2.28
113	Trichothiodystrophy 6, nonphotosensitive	Enrichment	GTF2E2	2.26
114	Neurodevelopmental disorder with severe motor impairment, absent language, cerebral hypomyelination, and brain atrophy	Enrichment	TAF8	2.26
115	Neurodevelopmental disorder with cerebellar hypoplasia and spasticity	Enrichment	INTS8	2.26
116	Alazami-yuan syndrome	Enrichment	TAF6	2.26
117	Intellectual developmental disorder, autosomal recessive 60	Enrichment	TAF13	2.26
118	Neurodevelopmental disorder with motor regression, progressive spastic paraplegia, and oromotor dysfunction	Enrichment	SNAPC4	2.26
119	Neurodevelopmental disorder with motor and language delay, ocular defects, and brain abnormalities	Enrichment	INTS11	2.26
120	Distal myopathy	Enrichment	HNRNPA1	2.24
121	Inclusion body myopathy with paget disease of bone and frontotemporal dementia	Enrichment	HNRNPA1	2.24
122	Trichothiodystrophy 1, photosensitive	Enrichment	ERCC2	2.22
123	Wieacker-wolff syndrome	Enrichment	CCNH	2.22
124	Intellectual developmental disorder, x-linked, syndromic 33	Enrichment	TAF1	2.22
125	Dystonia 3, torsion, x-linked	Enrichment	TAF1	2.22
126	Neurodevelopmental disorder with feeding difficulties, thin corpus callosum, and foot deformity	Enrichment	TAF2	2.22
127	Spermatogenic failure 13	Enrichment	TAF4B	2.22
128	X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome	Enrichment	TAF1	2.22
129	Adenoid cystic carcinoma	Enrichment	MYBL1	2.19
130	Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities	Enrichment	POLR2A	2.15
131	Intellectual developmental disorder, x-linked, syndromic, bain type	Enrichment	HNRNPH1	2.12
132	Intellectual disability, x-linked, syndromic, bain type	Enrichment	HNRNPH1	2.12
133	Craniopharyngioma	Enrichment	ERCC2	2.10
134	Charcot-marie-tooth hereditary neuropathy	Enrichment	TDRKH	2.07
135	Hyperparathyroidism 1	Enrichment	CDC73	2.07
136	14q11.2 microduplication syndrome	Enrichment	SUPT16H	2.07
137	Acute myeloid leukemia with t(9;11)(p22;q23)	Enrichment	MLLT3	2.07
138	Hypogonadotropic hypogonadism 1 with or without anosmia	Enrichment	POLR2F	2.05
139	Burkitt lymphoma	Enrichment	PMS2	2.04
140	Adrenocortical carcinoma, hereditary	Enrichment	TP53	2.04
141	Cervical cancer	Enrichment	TP53	2.04
142	Xeroderma pigmentosum, complementation group e	Enrichment	DDB2	2.04
143	Fanconi anemia, complementation group i	Enrichment	FANCI	2.04
144	Lymphoma, hodgkin, classic	Enrichment	TP53	2.04
145	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	Enrichment	CDK13	2.04
146	Fanconi anemia, complementation group s	Enrichment	BRCA1	2.04
147	Cardiac valvular dysplasia, x-linked	Enrichment	ATM	2.04
148	Pancreatic cancer 4	Enrichment	BRCA1	2.04
149	Congenital fibrosarcoma	Enrichment	TP53	2.04
150	High grade glioma	Enrichment	ATM	2.04
151	Li-fraumeni syndrome 1	Enrichment	TP53	2.04
152	Sarcoma	Enrichment	TP53	2.04
153	Cervix carcinoma	Enrichment	TP53	2.04
154	Hodgkin's lymphoma	Enrichment	TP53	2.04
155	T-cell prolymphocytic leukemia	Enrichment	ATM	2.04
156	Inflammatory breast carcinoma	Enrichment	BRCA1	2.04
157	Peritoneum cancer	Enrichment	BRCA1	2.04
158	Bilateral breast cancer	Enrichment	BRCA1	2.04
159	Xeroderma pigmentosum group e	Enrichment	DDB2	2.04
160	Pleomorphic rhabdomyosarcoma	Enrichment	TP53	2.04
161	Lung cancer	Enrichment	BRCA1, MLH1	2.03
162	Capillary malformations, congenital	Enrichment	CCNH	2.00
163	Waardenburg syndrome, type 4a	Enrichment	POLR2F	1.98
164	Waardenburg syndrome	Enrichment	POLR2F	1.98
165	Spinocerebellar ataxia 17	Enrichment	TBP	1.96
166	Neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies	Enrichment	INTS1	1.96
167	Cleft lip with or without cleft palate	Enrichment	ESRP2	1.94
168	Klippel-trenaunay-weber syndrome	Enrichment	CCNH	1.92
169	Cerebrooculofacioskeletal syndrome 1	Enrichment	ERCC2	1.92
170	Telangiectasia, hereditary hemorrhagic, type 1	Enrichment	CCNH	1.92
171	Hemangioma, capillary infantile	Enrichment	CCNH	1.92
172	Basal cell carcinoma 1	Enrichment	CCNH	1.92
173	Intellectual developmental disorder, autosomal dominant 73	Enrichment	TAF4	1.92
174	Waardenburg syndrome, type 1	Enrichment	POLR2F	1.91
175	Waardenburg syndrome, type 2e	Enrichment	POLR2F	1.91
176	Parathyroid adenoma	Enrichment	CDC73	1.89
177	Familial isolated hyperparathyroidism	Enrichment	CDC73	1.89
178	Ataxia-telangiectasia	Enrichment	ATM	1.86
179	Polycythemia vera	Enrichment	ATM	1.86
180	Osteogenic sarcoma	Enrichment	TP53	1.86
181	Nasopharyngeal carcinoma	Enrichment	TP53	1.86
182	Breast-ovarian cancer, familial 4	Enrichment	RAD51D	1.86
183	Koolen-de vries syndrome	Enrichment	ATM	1.86
184	Atypical teratoid rhabdoid tumor	Enrichment	TP53	1.86
185	Anaplastic astrocytoma	Enrichment	TP53	1.86
186	Squamous cell carcinoma	Enrichment	TP53	1.86
187	Cellular ependymoma	Enrichment	MSH2	1.86
188	Tanycytic ependymoma	Enrichment	MSH2	1.86
189	Papillary ependymoma	Enrichment	MSH2	1.86
190	Hereditary site-specific ovarian cancer syndrome	Enrichment	RAD51D	1.86
191	Bone osteosarcoma	Enrichment	TP53	1.86
192	Clear cell ependymoma	Enrichment	MSH2	1.86
193	Capillary malformation-arteriovenous malformation 1	Enrichment	CCNH	1.86
194	Hereditary hemorrhagic telangiectasia	Enrichment	CCNH	1.86
195	Leukemia, acute myeloid	Enrichment	FANCD2, TP53	1.84
196	Wolf-hirschhorn syndrome	Enrichment	NELFA	1.84
197	Inflammatory bowel disease 1	Enrichment	ERCC2	1.75
198	Arteriovenous malformation	Enrichment	CCNH	1.75
199	Hypotrichosis simplex	Enrichment	ERCC2	1.75
200	Small cell cancer of the lung	Enrichment	TP53	1.74
201	Erythrocytosis, familial, 2	Enrichment	FANCD2	1.74
202	Thyroid cancer, nonmedullary, 1	Enrichment	TP53	1.74
203	Polyposis syndrome, hereditary mixed, 1	Enrichment	BRCA1	1.74
204	Cholangiocarcinoma	Enrichment	BRCA1	1.74
205	Congenital generalized lipodystrophy	Enrichment	FOS	1.74
206	Mantle cell lymphoma	Enrichment	ATM	1.74
207	Lung sarcomatoid carcinoma	Enrichment	TP53	1.74
208	Benign ependymoma	Enrichment	MSH2	1.74
209	Oculomotor apraxia	Enrichment	ATM	1.74
210	Male infertility due to gonadal dysgenesis or sperm disorder	Enrichment	CHEK1	1.74
211	Myopathy, x-linked, with excessive autophagy	Enrichment	CCNH	1.70
212	Complex neurodevelopmental disorder	Enrichment	AGO1, AGO2	1.70
213	Fanconi anemia, complementation group d2	Enrichment	FANCD2	1.64
214	Von hippel-lindau syndrome	Enrichment	FANCD2	1.64
215	Rhabdomyosarcoma 2	Enrichment	TP53	1.64
216	Histiocytoid hemangioma	Enrichment	FOS	1.64
217	Acute megakaryocytic leukemia	Enrichment	TP53	1.64
218	Myeloma, multiple	Enrichment	ATM, TP53	1.57
219	Li-fraumeni syndrome	Enrichment	TP53	1.57
220	Adrenocortical carcinoma	Enrichment	TP53	1.57
221	Clear cell renal cell carcinoma	Enrichment	ATM	1.57
222	Breast adenocarcinoma	Enrichment	TP53	1.57
223	Corpus callosum, agenesis of	Enrichment	ERCC2	1.53
224	Isolated corpus callosum agenesis	Enrichment	ERCC2	1.53
225	Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome	Enrichment	ERCC2	1.53
226	Chondrosarcoma, extraskeletal myxoid	Enrichment	TAF15	1.53
227	Multiple endocrine neoplasia, type i	Enrichment	CDC73	1.53
228	Esophageal cancer	Enrichment	TP53	1.50
229	Mitochondrial dna depletion syndrome 4a	Enrichment	FANCI	1.50
230	Squamous cell carcinoma, head and neck	Enrichment	TP53	1.50
231	Renal cell carcinoma, papillary, 1	Enrichment	ATM	1.50
232	Essential thrombocythemia	Enrichment	TP53	1.50
233	Gallbladder cancer	Enrichment	TP53	1.50
234	B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)	Enrichment	TP53	1.50
235	Esophageal atresia/tracheoesophageal fistula	Enrichment	POLR2B	1.48
236	Glioma susceptibility 1	Enrichment	TP53	1.44
237	Fanconi anemia, complementation group c	Enrichment	FANCC	1.44
238	Lymphoma, non-hodgkin, familial	Enrichment	TP53	1.44
239	Leukodystrophy	Enrichment	ERCC2	1.41
240	Kallmann syndrome	Enrichment	POLR2F	1.40
241	Adult hepatocellular carcinoma	Enrichment	TP53	1.39
242	Primary hyperaldosteronism	Enrichment	TP53	1.39
243	Williams-beuren syndrome	Enrichment	FKBP6	1.38
244	Cornelia de lange syndrome 1	Enrichment	TAF6	1.32
245	Cornelia de lange syndrome	Enrichment	TAF6	1.32
246	Immune deficiency disease	Enrichment	ATM	1.31
247	Myelodysplastic syndrome	Enrichment	TP53	1.31
248	Cardiomyopathy, familial hypertrophic, 9	Enrichment	PMS2	1.31
249	Familial colorectal cancer type x	Enrichment	ATM	1.31
250	Hirschsprung disease 1	Enrichment	POLR2F	1.30
251	Lip and oral cavity carcinoma	Enrichment	TP53	1.27
252	Periventricular nodular heterotopia	Enrichment	BRCA1	1.21
253	Seckel syndrome	Enrichment	ATR	1.21
254	Wilms tumor 1	Enrichment	CTR9	1.21
255	Renal cell carcinoma, nonpapillary	Enrichment	ATM	1.18
256	Acute promyelocytic leukemia	Enrichment	NABP1	1.16
257	Heart, malformation of	Enrichment	CDK13	1.10
258	Syndromic intellectual disability	Enrichment	TAF6	1.05
259	Charcot-marie-tooth disease	Enrichment	CTDP1	1.02
260	Cardiomyopathy, dilated, 1g	Enrichment	PMS2	1.02
261	Parkinson's disease	Enrichment	TBP	1.01
262	Diamond-blackfan anemia 1	Enrichment	TP53	1.00
263	Frontotemporal dementia and/or amyotrophic lateral sclerosis 7	Enrichment	HNRNPA1	0.98
264	Parkinson disease, late-onset	Enrichment	TBP	0.91
265	Rare genetic deafness	Enrichment	POLR2F	0.88
266	Diamond-blackfan anemia	Enrichment	TP53	0.82
267	Primary autosomal recessive microcephaly	Enrichment	TAF13	0.79
268	West syndrome	Enrichment	MLLT1	0.76
269	Hypertelorism	Enrichment	MLLT1	0.70
270	Autism spectrum disorder	Enrichment	CDK13	0.40
271	Microcephaly	Enrichment	TAF8	0.31

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

Formation of HIV elongation complex in the absence of HIV Tat

Pathway Network for Formation of HIV elongation complex in the absence of HIV Tat

Pathway network for the Formation of HIV elongation complex in the absence of HIV Tat SuperPath

Member Pathways for Formation of HIV elongation complex in the absence of HIV Tat

Pathways in the Formation of HIV elongation complex in the absence of HIV Tat SuperPath

Gene overlap in member pathways for Formation of HIV elongation complex in the absence of HIV Tat SuperPath

Associated Genes for Formation of HIV elongation complex in the absence of HIV Tat

Associated Disorders for Formation of HIV elongation complex in the absence of HIV Tat

Disorders associated with Formation of HIV elongation complex in the absence of HIV Tat SuperPath

STRING Interaction Network for Formation of HIV elongation complex in the absence of HIV Tat

Sources for Formation of HIV elongation complex in the absence of HIV Tat